HIGHLIGHTS
- What: This study provides new ideas for the application of ICI therapy in GBM .
- Who: Hao Zhang from the University, China have published the Article: Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma, in the Journal: (JOURNAL)
- Future: Currently relatively little research is available on the mechanism and efficacy of the gut microbiota in GBM and further research is required to verify its specific effects and potential therapeutic value.
SUMMARY
ICIs can relieve the inhibitory state of the patient`s immune system and activate T_cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.